PGR and inflammatory breast carcinoma: The key considerations when selecting whether to start adjuvant or neoadjuvant chemotherapy for patients with IBC-NSTs are tumour size, nodal status, nuclear grade, age, tumour subtype determined by IHC for ER, PgR, and HER2, and the Ki67 index.